Should you build or buy Clinical Decision Support (CDS)?
Clinical Decision Support software delivers point-of-care guidance to clinicians, including drug interaction checking, diagnostic reference content, order sets and alert rules, drawing on continuously maintained medical evidence and drug databases. Hospitals and health systems buy it to reduce prescribing errors and keep care aligned with current clinical guidelines.
Buy the curated clinical and drug knowledge; own the local alert logic, order sets and governance that sit on top of it, and treat any LLM assistant as retrieval with clinician review rather than a replacement for validated interaction checking.
Build it, buy it, or bridge?
When building makes sense
Health systems with real informatics capacity have built credible pieces of this category. CHOP runs a homegrown Care Assistant framework, developed with researchers at PolicyLab and DBHi, across immunization, HPV vaccine, and premature-infant care projects inside its EMR. Mass General Brigham governs 876 locally authored alert rules that fired 21.3 million times between 2019 and 2022. Cliniques universitaires Saint-Luc deployed an on-premises, GDPR-compliant retrieval assistant built on Qwen3-235B inside its Epic EHR. After a one-month pilot with 28 physicians, the hospital rolled it out system-wide: it was adopted by 1,028 users who generated 14,910 conversations over five months, with more than half of clinicians using it at least weekly. AI coding tools made a project like Saint-Luc's realistic for a single hospital's engineering team to attempt. None of these systems replaced their licensed drug and evidence database. What they built was the local rules layer and a retrieval interface on top of content someone else maintains.
When buying makes sense
Buy the underlying clinical and drug knowledge, because no hospital engineering team reproduces it economically. UpToDate, DynaMed, Micromedex and ClinicalKey exist because keeping drug interaction data and clinical evidence current across every specialty is continuous, expert-driven work with real liability attached. Building that in-house is not a project a health system's IT budget or malpractice exposure can absorb. AI does not remove the need to buy: an independent safety review found that Penda Health's LLM-based consult tool made potentially harmful recommendations in 7.8 percent of reviewed encounters, and a later randomized trial showed no significant outcome difference. That result argues for retrieval with clinician review rather than an AI system replacing validated content. Buy the evidence and drug database, keep local alert rules, order sets and governance in-house, and treat any AI assistant layered on top as retrieval augmented by your own clinicians.
The desk read
Build-versus-buy analysis for Clinical Decision Support (CDS) is being written. In the meantime, the framework that drives every B4 call is on the B4 Index page.
Frequently asked
What is Clinical Decision Support (CDS) software?
It is the point-of-care layer built on top of a licensed evidence base. Cliniques universitaires Saint-Luc's retrieval assistant, for example, drew on structured patient data plus internal and regional clinical documents rather than replacing the licensed drug and evidence content underneath it.
Have hospitals built their own clinical decision support?
Yes, for the local rules layer. CHOP runs a homegrown Care Assistant framework across immunization, HPV vaccine, and premature-infant care projects, Mass General Brigham governs 876 locally authored alerts, and Saint-Luc deployed an in-house retrieval assistant adopted by over 1,000 clinicians. None replaced their licensed drug and evidence database.
Can AI replace a clinical drug interaction database?
Not reliably yet. An independent safety review found Penda Health's LLM-based consult tool made potentially harmful recommendations in 7.8 percent of reviewed encounters, and a follow-up trial found no significant outcome improvement. Treat AI as retrieval with clinician review, alongside validated interaction checking rather than in place of it.
What are the main CDS vendors?
Representative vendors include EBSCO DynaMed, Elsevier ClinicalKey. B4 Pro includes the category score and the full vendor list.